Source:http://linkedlifedata.com/resource/pubmed/id/11517127
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-8-22
|
pubmed:abstractText |
We assessed the feasibility and efficacy of subcutaneous erythropoietin alpha (EPO) therapy and preoperative autologous blood donation (ABD) in children undergoing open heart surgery. Thirty-nine children were treated consecutively with EPO (100 U x kg(-1) s.c. three times a week in the 3 weeks preceding the operation and i.v. on the day of surgery) and two ABDs were made (Group 1). As controls to compare transfusion requirements, 39 consecutive age-matched patients who had undergone open heart surgery during the two preceding years were selected (Group 2). In a mean time of 20 (SD 5) days, 96% of scheduled ABDs were performed and only three mild vasovagal reactions were observed. The mean volume of autologous red blood cells (RBC) collected was 6 (1) ml x kg(-1) and the mean volume of autologous RBC produced as a result of EPO therapy before surgery was 7 (3) ml x kg(-1), corresponding to a 28 (11)% increase in circulating RBC volume. The mean volume of autologous RBC collected was not different from that produced [6 (1) vs 7 (3) ml x kg(-1), P=0.4]. Allogenic blood was administered to three out of 39 children in Group 1 (7.7%) and to 24 out of 39 (61.5%) in Group 2. Treatment with subcutaneous EPO increases the amount of autologous blood that can be collected and minimizes allogenic blood exposure in children undergoing open heart surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-0912
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
429-34
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11517127-Adolescent,
pubmed-meshheading:11517127-Blood Loss, Surgical,
pubmed-meshheading:11517127-Blood Transfusion, Autologous,
pubmed-meshheading:11517127-Cardiopulmonary Bypass,
pubmed-meshheading:11517127-Child,
pubmed-meshheading:11517127-Child, Preschool,
pubmed-meshheading:11517127-Erythropoietin,
pubmed-meshheading:11517127-Feasibility Studies,
pubmed-meshheading:11517127-Female,
pubmed-meshheading:11517127-Heart Defects, Congenital,
pubmed-meshheading:11517127-Hemoglobins,
pubmed-meshheading:11517127-Humans,
pubmed-meshheading:11517127-Infant,
pubmed-meshheading:11517127-Male,
pubmed-meshheading:11517127-Platelet Count,
pubmed-meshheading:11517127-Preoperative Care,
pubmed-meshheading:11517127-Tissue and Organ Harvesting
|
pubmed:year |
2001
|
pubmed:articleTitle |
Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery.
|
pubmed:affiliation |
Department of Anesthesiology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|